METHODS AND COMPOSITIONS FOR TREATING UNDESIRED IMPLANTED TISSUE FILLER

A method for treating undesired implanted calcium phosphate tissue filler by administering an effective amount of a pharmaceutically acceptable hyperosmotic composition. The hyperosmotic composition may be hyperosmotic solution, particularly a hyperosmotic aqueous solution. The hyperosmotic composit...

Full description

Saved in:
Bibliographic Details
Main Authors PLITT, Patrick, DANYSZ, Wojciech, KREYMERMAN, Peter
Format Patent
LanguageEnglish
French
German
Published 13.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method for treating undesired implanted calcium phosphate tissue filler by administering an effective amount of a pharmaceutically acceptable hyperosmotic composition. The hyperosmotic composition may be hyperosmotic solution, particularly a hyperosmotic aqueous solution. The hyperosmotic composition is administration to an area containing the undesired calcium phosphate tissue filler. Administration of the hyperosmotic composition can reduce, dilute/or redistribute an undesired amount or accumulation of implanted calcium phosphate tissue filler implanted. Methods herein can ameliorate undesired filler that is implanted in an undesired or unintended location, that migrates to an undesired location, that results in an undesired visual result, and/or that results in undesired compression of surrounding tissue, and/or that results in pain, infection, and/or inflammation.
Bibliography:Application Number: EP20200817901